Melanoma brain metastases outcomes following nivolumab and relatlimab after ipilimumab and nivolumab progression.
0/5 보강
APA
Khatri VM, Aboujaoude M, et al. (2026). Melanoma brain metastases outcomes following nivolumab and relatlimab after ipilimumab and nivolumab progression.. Journal of neuro-oncology, 177(1). https://doi.org/10.1007/s11060-026-05510-w
MLA
Khatri VM, et al.. "Melanoma brain metastases outcomes following nivolumab and relatlimab after ipilimumab and nivolumab progression.." Journal of neuro-oncology, vol. 177, no. 1, 2026.
PMID
41801545 ↗
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Successful Treatment of Paranasal Sinus Metastasis From Renal Cell Carcinoma With Immune Checkpoint Inhibitors and Radiotherapy: A Case Report.
- Nanoparticle Albumin-Bound Paclitaxel and Nivolumab for PD-1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma.
- Efficacy and safety of nivolumab plus chemotherapy in patients with advanced gastric cancer with massive ascites.
- Severe Myocarditis after Nivolumab and Ipilimumab in a Patient with Microsatellite Instability-High Gastric Adenocarcinoma: A Case Report.
- Immune checkpoint inhibitor-induced myocarditis with atrioventricular conduction abnormalities: a case report.
- Evaluation of mixed response in tumor size and survival in patients with rare cancers treated with dual checkpoint inhibitor therapy (DART SWOG S1609).